Table 3 Genotypes and allelic frequencies of ACE I/D and ACE G2350A genes in diabetic Patient and control groups.

From: Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM

Genotypes/alleles

Diabetic patients group (n = 108)

Control group (n = 85)

χ2

P value

ACE I/D

 Genotype (n)

  II

11 (10.2%)

7 (8.2%)

6.03

0.049*

  ID

60 (55.6%)

34 (40%)

  

  DD

37 (34.2%)

44 (51.8%)

  

 Allele (2n)

 

  D

134

122

  

  I

82

48

  

ACE (G2350A)

 Genotype (n)

  GG

33 (30.6%)

47 (55.3%)

14.8

0.001**

  GA

47 (43.5%)

30 (35.3%)

 

  AA

28 (25.9%)

8 (9.4%)

 

 Allele (2n)

  G

113 (52.3%)

124 (72.9%)

 

  A

103 (47.7%)

46 (27.1%)

 
  1. **High significant p < 0.001, *significant at p < 0.05.